Preference of acromegaly patients for treatment attributes in Spain

被引:0
|
作者
Fajardo, Carmen [1 ]
Alvarez-Escola, Cristina [2 ]
Biagetti, Betina [3 ,4 ]
Garcia-Centeno, Rogelio [5 ]
Ciriza, Raquel [6 ]
Sanchez-Cenizo, Laura [7 ]
Diaz-Munoz, Marcos [7 ]
机构
[1] Ribera Univ Hosp, Endocrinol Dept, Alzira, Valencia, Spain
[2] La Paz Univ Hosp, Endocrinol Dept, Madrid, Spain
[3] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Diabet & Metab Res Unit, Barcelona, Spain
[4] Univ Autonoma Barcelona, Vall Hebron Res Inst VHIR, Barcelona, Spain
[5] Gregorio Maranon Univ Hosp, Endocrinol Dept, Madrid, Spain
[6] Spanish Assoc People Affected Acromegaly Asociac P, Huesca, Spain
[7] Pfizer SLU, Med Affairs Dept, Alcobendas, Madrid, Spain
关键词
Acromegaly; Growth hormone; Quality of life; Treatment; Preferences; QUALITY-OF-LIFE; DIAGNOSIS; DISEASE; QUESTIONNAIRE; PERCEPTIONS; PEGVISOMANT; PASIREOTIDE; EXPERIENCE; MANAGEMENT; PITUITARY;
D O I
10.1007/s12020-023-03462-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveAcromegaly is a rare disease caused by increased growth hormone secretion and a subsequent increase in insulin-like growth factor I (IGF-I) levels. Patients display multiple comorbidities that affect their quality of life (QoL). Treatment aims to maintain good biochemical control, tumour control and reduce the risk of comorbidities; however, their impact on QoL has been overlooked until recently. We interviewed patients to explore their preferences with regard to treatment attributes.DesignA cross-sectional study based on interviews and a discrete choice experiment (DCE) in a Spanish cohort.MethodsAdult patients diagnosed with acromegaly & GE;1 year before the start of the study and under treatment were included. Treatment attributes were collected from patient testimony during face-to-face interviews. Then, a DCE was performed to elicit patient preferences for certain treatment attributes.ResultsSixty-seven patients completed the study. QoL improvement was the most important treatment attribute (37%), followed by IGF-I control (20%), blood sugar control (17%) and tumour control (13%). Secondary attributes were pain associated with the route of administration (7%), diarrhoea (2%), administration method (2%) and storage conditions (2%). We then calculated the theoretical share of preference for existing treatments, based on the individual preference utility for each attribute and level. Pegvisomant obtained the highest share of preference overall, and the highest preference as a second-line treatment (53 and 95%, respectively).ConclusionsQoL greatly influences patient treatment preference. Since acromegaly patients are informed and aware of their disease, treatment choices should always be shared with patients.
引用
收藏
页码:379 / 389
页数:11
相关论文
共 50 条
  • [41] Utility of verapamil in the treatment of diastolic dysfunction in patients with acromegaly
    Ortuño, FM
    Payá, VEC
    Alfonso, AMP
    Martínez, JGM
    Payá, JS
    Garri, FS
    REVISTA CLINICA ESPANOLA, 2003, 203 (01): : 15 - 19
  • [42] TREATMENT OF ACROMEGALY
    QUABBE, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 107 (27) : 1060 - 1063
  • [43] TREATMENT OF ACROMEGALY
    KJELLBERG, RN
    KLIMAN, B
    LANCET, 1975, 1 (7907): : 630 - 631
  • [44] TREATMENT OF ACROMEGALY
    HARRIS, P
    HUNTER, WM
    STEEL, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1968, 31 (01): : 85 - &
  • [45] THE TREATMENT OF ACROMEGALY
    WASS, JAH
    LAWS, ER
    RANDALL, RV
    SHELINE, GE
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1986, 15 (03): : 683 - 707
  • [46] TREATMENT OF ACROMEGALY
    ALOIA, JF
    FIELD, RA
    KRAMER, S
    ARCHIVES OF INTERNAL MEDICINE, 1973, 131 (04) : 509 - 515
  • [47] Treatment of acromegaly
    Utiger, RD
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (16): : 1210 - 1211
  • [48] TREATMENT OF ACROMEGALY
    LAMBERTS, SWJ
    KLIJN, JGM
    DELANGE, SA
    BIRKENHAGER, JC
    NETHERLANDS JOURNAL OF MEDICINE, 1979, 22 (05): : 161 - 166
  • [49] TREATMENT OF ACROMEGALY
    不详
    LANCET, 1974, 2 (7895): : 1490 - 1491
  • [50] TREATMENT OF ACROMEGALY
    PEARSON, OH
    KAUFMAN, B
    BRODKEY, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1970, 283 (18): : 999 - &